AbbVie Board Recommends Vote Against Shire Deal

The transcript discusses the market's reaction to a failed deal, highlighting the board's recommendation against it and its significance as a major US takeover in Europe. It also examines the impact of the US crackdown on tax inversions, noting increased skepticism and the failure of high-profile inversion attempts like Pfizer-AstraZeneca and Abshire. The challenges of executing such deals due to political opposition and regulatory scrutiny are emphasized.

What was the market's conclusion regarding the deal mentioned in the text?

What is the significance of the shareholder vote by AbbVie investors?

How have recent political actions affected large market transactions?

What were the reasons for the failure of the attempted inversions mentioned?

What challenges do companies face when attempting large inversions?